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OBJECTIVES We sought to determine the usefulness of brain natriuretic peptide (BNP) measurements to
differentiate constrictive pericarditis (CP) from restrictive cardiomyopathy (RCMP).
BACKGROUND The differentiation of CP from RCMP may be clinically difficult and often requires
hemodynamic assessment. No laboratory marker has been shown to differentiate the two
conditions.
METHODS Wemeasured BNP levels in 11 patients suspected of having either CP or RCMP. All patients
had hemodynamic assessment the day of BNP measurements.
RESULTS Six patients had CP and five patients had RCMP based on established hemodynamic criteria.
Both CP and RCMP patients had similar elevation in intracardiac pressures. Despite similar
pressures, the mean plasma BNP levels were significantly higher in RCMP compared to CP
(825.8  172.2 pg/ml vs. 128.0  52.7 pg/ml, p  0.001, respectively).
CONCLUSIONS The BNP levels are significantly elevated in RCMP compared to CP patients; BNP may
prove to be a useful noninvasive marker for the differentiation of the two conditions. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.03.050Coll Cardiol 2005;45:1900–2) © 2005 by the American College of Cardiology Foundation
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vestrictive cardiomyopathies (RCMP) such as amyloidosis
nd diseases of the pericardium cause impairment of dia-
tolic function of the heart (1). Although etiologies of these
iseases and their prognosis differ, they result in common
linical presentation that often leads to difficulty in making
specific diagnosis. In addition to patient history, physical
xamination, and traditional hemodynamic assessment, cli-
icians have recently relied on noninvasive techniques such
s Doppler echocardiography, computed tomography, and
agnetic resonance imaging to differentiate between the
wo states (1–5). However, there are no readily available
lood markers to diagnose these states with a high degree of
ensitivity and specificity.
Brain natriuretic peptide (BNP) is a cardiac hormone,
ynthesized by ventricular myocytes in response to ven-
ricular dysfunction and wall stretch. Plasma BNP levels
re increased in congestive heart failure exacerbations,
hether due to systolic or diastolic dysfunction (6,7). In
onstrictive pericarditis (CP) the myocardium is intrin-
ically normal, and myocardial stretch is prevented by the
onstraining pericardium. Given that myocardial stretch
s the predominant mechanism of BNP release, we
ostulated that the plasma BNP levels in CP would be
ow, despite elevated intracardiac pressures (8 –10). It has
een known that atrial natriuretic peptide is only mod-
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ccepted March 29, 2005.stly elevated in cardiac tamponade where there is no
yocardial stretch. Thus, it has been speculated that
atriuretic peptides may only be modestly elevated in CP
s well (11). However, to date there has been no data
egarding BNP and CP. The aim of this study was to
ssess the efficacy and reliability of plasma BNP levels in
he differentiation of CP and RCMP.
ETHODS
e prospectively enrolled 11 consecutive patients undergo-
ng invasive hemodynamic assessment for the evaluation of
P or RCMP at Loyola University Medical Center during
une 2003 to December 2004. Patients being evaluated for
P or RCMP had BNP levels drawn before or immediately
fter invasive hemodynamic assessment; BNP assay samples
ere processed and analyzed using the ADVIA Centaur
ystem (Bayer, Tarrytown, New York). All patients who had
ossible constriction or RCMP and who needed hemody-
amic study were eligible for the study. All patients were in
ew York Heart Association functional class III or IV.
eart transplant recipients or patients suspected of having
oth CP and RCMP were excluded from the study. All
atients underwent left and right heart catheterization as
art of clinical workup. When optimal pulmonary capillary
edge pressures (PCWP) could not be obtained, patients
nderwent transseptal catheterization with measurement of
eft atrial pressures (LAP). A respirometer was used to
onitor respiration during pressure recording. Rapid intra-
ascular volume expansion using 1,000 cc of normal saline at
8°C given over 10 min was used to identify hidden diastolic
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June 7, 2005:1900–2 BNP Levels in Constrictive Cardiomyopathylling abnormalities. Fluid challenge expands blood volume,
hich would demonstrate equalization of diastolic pressure
o diagnose occult constriction.
Left ventricular ejection fraction was estimated by either
chocardiography or left ventriculography. No medications
ere held before hemodynamic measurements, and no
edications were given during hemodynamic measure-
ents.
The diagnosis of either CP or RCMP was based on the
ollowing hemodynamic criteria: elevation and near equal-
zation of all diastolic pressures, absence of inspiratory
ariation of right atrial pressure (RAP), exaggerated Y
escent, and the square root sign on ventricular pressure
urves. For the diagnosis of CP, the following criteria were
eeded: the presence of intracardiac and intrathoracic dis-
ociation and the presence of ventricular discordance. In
ddition, when indicated, the CP diagnosis was confirmed
t surgery. Hemodynamic data recorded RAP, LAP by
ransseptal catheterization, pulmonary artery pressure
PAP), PCWP, left ventricular end-diastolic pressure
LVEDP) at plateau, right ventricular end-diastolic pres-
ure, left ventricular ejection fraction.
Continuous data are presented as mean  SD. All p
alues were two-sided, with values 0.05 considered sig-
ificant. Descriptive statistics, Student t tests, and Fisher
xact tests were performed to assess the data between CP
nd RCMP patients. The Institution Research Board Re-
iew Committee approved the protocol.
Abbreviations and Acronyms
BNP  brain natriuretic peptide
CP  constrictive pericarditis
LAP  left atrial pressure
LVEDP  left ventricular end-diastolic pressure
PAP  pulmonary artery pressure
PCWP  pulmonary capillary wedge pressure
RAP  right atrial pressure
RCMP  restrictive cardiomyopathy
able 1. Patient Characteristics and Hemodynamic Measurement
t. Disease
Age
(yrs) Gender
BNP
(pg/ml)
LAP
(mm Hg)
P
(m
1 CP 61 M 88 NA
2 CP 66 M 179 25
3 CP 47 M 50 21
4 CP 61 F 143 40
5 CP 81 F 124 30
6 CP 69 M 186 27
7 RCMP 69 M 1,060 33
8 RCMP 73 F 728 33
9 RCMP 24 M 756 27
10 RCMP 59 F 946 NA
11 RCMP 46 F 639 28
NP  brain natriuretic peptide; CP  constrictive pericarditis; LAP  left atrial pr
raction; NA  not able to measure; PAP  pulmonary artery pressure; PCWP  pulm
ardiomyopathy.ESULTS
leven patients had hemodynamic confirmation of either
P or RCMP. Six patients had CP and five had RCMP.
our of the six CP patients had surgical confirmation of the
isease and underwent pericardial stripping. Two CP pa-
ients refused surgery. All 11 patients had evidence of
levated intracardiac pressures with near equalization of all
iastolic pressures. The baseline characteristics and hemo-
ynamic data of the patients are summarized in Tables 1
nd 2. There were four men in the CP group and two men
n the RCMP group. Five of six CP patients were on a
iuretic, and four of five RCMP patients were on diuretic
herapy. The majority of CP (four of six) and RCMP (three
f five) patients were on angiotensin-converting enzyme
nhibitors. The majority of CP patients were also on
eta-blockers (four of six) and spironolactones (three of six)
hile only one patient each was on beta-blockers or spi-
onolactone in the RCMP group. Duration of illness varied
n the two groups from months to years.
There was no significant difference in the mean RAP,
AP, LAP, PCWP, and LVEDP between the two groups
Tables 1 and 2). The mean plasma BNP levels were
ignificantly higher in RCMP compared to CP (825.8 
72.2 pg/ml vs. 128.0  52.7 pg/ml, p  0.001, respec-
ively) (Fig. 1). Median values of BNP were 143 pg/ml (50
o 186 pg/ml) in the CP group and 756 pg/ml (639 to 1,060
g/ml) in the RCMP group (p  0.001). The normal range
f BNP is 0 to 100 pg/ml.
One patient was excluded in the CP group because he
lso had severe aortic insufficiency and moderate mitral
egurgitation. His BNP was 303 pg/ml with impaired left
entricular ejection fraction of 30%.
ISCUSSION
he accurate differentiation of CP versus RCMP consti-
utes a diagnostic challenge even to experienced clinicians.
he clinical signs of diastolic heart failure reflect the degree
f systemic and central venous congestion with either subtle
P
g)
LVEDP
(mm Hg)
PAP
(mm Hg)
RA
(mm Hg)
LVEF
(%)
Prior
Surgery
21 35 16 60 Yes
27 27 19 60 No
24 24 20 60 No
25 24 22 60 No
29 47 28 60 Yes
21 41 23 60 Yes
20 34 17 30 Yes
17 49 13 60 No
31 27 23 60 Yes
34 37 34 55 No
31 42 19 40 No
; LVEDP  left ventricular end-diastolic pressure; LVEF  left ventricular ejections
CW
m H
35
28
21
40
NA
NA
35
36
30
34
28
essure
onary capillary wedge pressure; RAP  right atrial pressure; RCMP  restrictive
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BNP Levels in Constrictive Cardiomyopathy June 7, 2005:1900–2r overt fluid retention. Venous congestion, ascites, pedal
dema, dyspnea on exertion, easy fatigability, and occasional
rthopnea, which are caused by low cardiac output and
ncreased lung stiffness due to interstitial but not alveolar
dema, are found in both disease states. The basic challenge
acing clinicians is to reliably distinguish between constric-
ion’s ventricular filling impairment from pericardial con-
traint versus restriction’s ventricular filling impairment
rom impaired relaxation and decreased compliance in the
ace of overlapping signs and symptoms of congestion, and
requently nondiscriminating test results.
Our study is the first to use a readily available blood
arker to differentiate constriction versus restriction among
atients presenting with diastolic heart failure. Our study
rovides a novel observation that the level of BNP is
levated in patients with restriction while it is nearly normal
n those with constriction. While there has been a study to
how that plasma levels of BNP and BNP receptors are
levated in patients with RCMP, there was no data dem-
nstrating the usefulness of BNP measurement in differen-
iating constriction from restriction (10,12). Although atrial
atriuretic peptide is known to be modestly increased in
atients with CP compared to congestive heart failure from
ther etiology, there has not been direct comparison be-
ween CP versus RCMP (11). Our data demonstrates that
lasma BNP are “nearly normal” in patients with constric-
ive physiology of heart failure, and are grossly elevated in
atients with restrictive physiology of heart failure despite
early identical clinical and hemodynamic presentation.
lthough our patients had similar degrees of congestion,
nd nearly the same intracardiac pressure overload, their
NP response was strikingly different, which means that
heir underlying pathophysiologic mechanism of BNP re-
ease or BNP kinetics are different in constriction as
pposed to restriction. It has been postulated that despite
dentical intracardiac diastolic pressures, the transmural
istending pressure and forces are distinctly different be-
ween the two. In constriction, the intracardiac distending
ressure is effectively counterbalanced by a stress force of
hickened and constricting pericardium. The absence of
ardiac stretch causes a decrease in the transmural wall
ension that may lead to lower BNP release. Based on our
ata, BNP may be useful as a point-of-care triage in patients
n whom diagnosis of CP or RCMP is difficult. As seen in
ur study, four of six CP patients received angiotensin-
able 2. Hemodynamic Measurements Between CP and RCMP
Group CP RCMP p Value
AP (mm Hg) 28.6  7.2 30.3  3.2 0.69
VEDP (mm Hg) 24.5  3.2 26.6  7.6 0.55
AP (mm Hg) 33.0  9.6 37.8  8.3 0.40
AP (mm Hg) 21.3  4.1 21.2  8.0 0.97
CWP (mm Hg) 31.0  8.3 32.6  3.4 0.70
VEF (%) 60.0  0.0 49.0  13.4 0.07
ata is presented as mean  standard deviation with 95% confidence interval.
Abbreviations as in Table 1.onverting enzyme inhibitors and beta-blockers, which may
e harmful in patients with CP.
Our study is limited by small sample size. We have
xcluded from our study patients with combined constric-
ive/restrictive pathologies such as heart transplant patients
nd patients with history of radiation-induced cardiomyop-
thies. We also excluded patients with concomitant valvular
isease. These patients must be studied separately to deter-
ine if BNP has any meaningful diagnostic role for them.
n our study we only measured BNP. A larger multicenter
egistry is needed to determine sensitivity, specificity, pre-
ictive accuracy, and limitations of plasma BNP levels in
ifferentiating constriction from restriction.
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